Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Adherence to Preventative Inhaled Therapy and Outcomes for People With Cystic Fibrosis Who Take Ivacaftor/Tezacaftor/Elexacaftor.

NCT05519020 is registered in ClinicalTrials.gov with Sheffield Teaching Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT05519020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05519020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Adherence to Preventative Inhaled Therapy and Outcomes for People With Cystic Fibrosis Who Take Ivacaftor/Tezacaftor/Elexacaftor.
Lead sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Completed
Start date
July 27, 2022
Completion date
October 31, 2024
Enrollment
1,385 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis